Your browser doesn't support javascript.
loading
A macrophage-targeted platform for extending drug dosing with polymer prodrugs for pulmonary infection prophylaxis.
Chavas, Thomas E J; Su, Fang-Yi; Srinivasan, Selvi; Roy, Debashish; Lee, Brian; Lovelace-Macon, Lara; Rerolle, Guilhem F; Limqueco, Elaine; Skerrett, Shawn J; Ratner, Daniel M; West, T Eoin; Stayton, Patrick S.
Afiliación
  • Chavas TEJ; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
  • Su FY; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
  • Srinivasan S; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
  • Roy D; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
  • Lee B; Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, Washington 98104, United States.
  • Lovelace-Macon L; Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, Washington 98104, United States; Department of Global Health, University of Washington, Seattle, Washington 98195, United States.
  • Rerolle GF; Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, Washington 98104, United States; Department of Global Health, University of Washington, Seattle, Washington 98195, United States.
  • Limqueco E; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
  • Skerrett SJ; Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, Washington 98104, United States. Electronic address: shawn@uw.edu.
  • Ratner DM; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States. Electronic address: dratner@uw.edu.
  • West TE; Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, Washington 98104, United States; Department of Global Health, University of Washington, Seattle, Washington 98195, United States. Electronic address: tewest@uw.edu.
  • Stayton PS; Department of Bioengineering, University of Washington, Seattle, Washington 98195, United States. Electronic address: stayton@uw.edu.
J Control Release ; 330: 284-292, 2021 02 10.
Article en En | MEDLINE | ID: mdl-33221351
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_transmissiveis / 2_cobertura_universal / 4_melioidosis Asunto principal: Profármacos / Melioidosis Límite: Animals / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_transmissiveis / 2_cobertura_universal / 4_melioidosis Asunto principal: Profármacos / Melioidosis Límite: Animals / Humans Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos